Drugs/Recall·openFDA/drug

Safecor Health, LLC — Class II: Fluphenazine HCl Elixir, USP, 5 mg per 10 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 1

MediumPublished Sep 23, 2026· AI-analyzed Sep 29, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Safecor Health, LLC has initiated a Class II recall for Fluphenazine HCl Elixir, USP (5 mg per 10 mL) due to failed stability specifications. The recall is currently classified as ongoing and affects product packaged by the firm's Woburn, MA facility.

Who it affects

This affects Safecor Health, LLC, healthcare providers, and pharmacy distributors utilizing this specific NDC (00121-0654-16) of Fluphenazine HCl Elixir. Quality and compliance personnel at repackaging facilities are also affected.

Why it matters

A Class II recall due to stability failure suggests that the product may not maintain its labeled potency or physical characteristics throughout its shelf life. For regulatory professionals, this underscores the importance of robust stability programs for repackaged liquid oral dosage forms, particularly those containing alcohol, which may be susceptible to evaporation or degradation. Failure to meet USP specifications indicates a potential lapse in manufacturing or environmental controls.

Practical takeaway

Quality units should verify if affected lots are in inventory and initiate quarantine procedures. Regulatory and QA teams should review stability testing protocols and retain sample data to ensure ongoing compliance with USP specifications for elixir formulations.

FDA source material

Class II. Reason: Failed Stability Specifications. Product: Fluphenazine HCl Elixir, USP, 5 mg per 10 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health, Woburn, MA 01801. NDC: 00121-0654-16. Firm: Safecor Health, LLC (Woburn MA United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.